Histoplasmosis in patients with cell-mediated immunodeficiency: Human immunodeficiency virus infection, organ transplantation, and tumor necrosis factor-α inhibition

Open Forum Infectious Diseases

Volumn 2, Issue 1, 2015, Pages

  Luckett, Keith ^a   Stephen Dummer, J ^b   Miller, Geraldine ^b   Hester, Sydney ^c   Thomas, Lora ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c CENTENNIAL MEDICAL CENTER   (United States)

Author keywords

Histoplasmosis; HIV; TNF inhibitors; Transplant

Indexed keywords

ADALIMUMAB; AMPHOTERICIN B; INFLIXIMAB; ITRACONAZOLE; POSACONAZOLE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VORICONAZOLE;

ADULT; AGED; ARTICLE; CELLULAR IMMUNODEFICIENCY; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; FEMALE; HISTOPLASMA; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATORY BOWEL DISEASE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SHORT COURSE THERAPY; SPONDYLOARTHROPATHY; THROMBOCYTOPENIA;

EID: 84978328519     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofu116     Document Type: Article

References (13)

1. Tobon AM, Agudelo CA, Rosero DS, et al. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg 2005; 73:576-82.
2. Deodhar D, Frenzen F, Rupali P, et al. Disseminated histoplasmosis: a comparative study of the clinical features and outcome among immunocompromised and immunocompetent patients. Natl Med J India 2013; 26:214-5.
3. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990; 69:361-74.
4. Baddley JW, Sankara IR, Rodriquez JM, et al. Histoplasmosis in HIVinfected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy. Diagn Microbiol Infect Dis 2008; 62:151-6.
5. Cuellar-Rodriguez J, Avery RK, Lard M, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009; 49:710-6.
6. Freifeld AG, Iwen PC, Lesiak BL, et al. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis 2005; 7:109-15.
7. Assi M, Martin S, Wheat LJ, et al. Histoplasmosis after solid organ transplantation. Clin Infect Dis 2013; 57:1542-9.
8. Tsiodras S, Samonis G, Boumpas DT, et al. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc 2008; 83:181-94.
9. McKinsey DS, Spiegel RA, Hutwagner L, et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis 1997; 24: 1195-203.
10. Hage CA, Bowyer S, Tarvin S, et al. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis 2010; 50:85-92.
11. Hage CA, Ribes JA, Wengenack NL, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis 2011; 53:448-54.
12. Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45:807-25.
13. Goldman M, Zackin R, FichtenbaumCJ, et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis 2004; 38:1485-9.